Berry Richard B, Sriram Peruvemba
Malcom Randall VA Medical Center, University of Florida, Gainesville, FL.
J Clin Sleep Med. 2014 Dec 15;10(12):1269-75. doi: 10.5664/jcsm.4272.
Compare auto-adjusting positive airway pressure (APAP) treatment with positive airway pressure (PAP) titration by polysomnography (PSG) followed by CPAP treatment in patients diagnosed with obstructive sleep apnea (OSA) by home sleep apnea testing (HSAT).
Prospective randomized treatment study.
Tertiary Veterans Administration Medical Center.
156 patients diagnosed with OSA by HSAT (apneahypopnea index [AHI] ≥ 10/h) suitable for APAP treatment.
APAP arm: Treatment with an APAP device, CPAP arm: PSG PAP titration followed by CPAP treatment.
Mean PAP adherence, Epworth sleepiness scale (ESS), Functional Outcomes of Sleep Questionnaire (FOSQ).
The mean (± SD) age, BMI, and diagnostic AHI (APAP: 28.6 ± 18.5, CPAP: 28.3 ± 16.0/h, p = NS) did not differ between the study arms. After 6 weeks of treatment, 84.6% of 78 patients started on APAP and 84.3% of 70 patients started on CPAP (8 declined treatment after the titration) were using PAP, p = NS. The 90% APAP and level of CPAP were similar (10.8 ± 3.1, 11.7 ± 2.5 cm H2O, p = 0.07). The average nightly PAP use did not differ (APAP: 4.45 ± 2.3, CPAP: 4.0 ± 2.3 h, p = NS). The improvements in the ESS (APAP: -4.2 ± 4.7, CPAP: -3.7 ± 4.8, p = NS) and in the FOSQ (APAP: 2.6 ± 3.5, CPAP: 2.2 ± 3.7, p = NS) were not different.
Following diagnosis of OSA by HSAT, treatment with APAP results in equivalent PAP adherence and improvement in sleepiness compared to a PSG titration and CPAP treatment.
A commentary on this article appears in this issue on page 1277.
比较自动调压气道正压通气(APAP)治疗与通过多导睡眠图(PSG)进行气道正压通气(PAP)滴定,随后进行持续气道正压通气(CPAP)治疗,用于经家庭睡眠呼吸暂停测试(HSAT)诊断为阻塞性睡眠呼吸暂停(OSA)的患者。
前瞻性随机治疗研究。
三级退伍军人管理局医疗中心。
156例经HSAT诊断为OSA(呼吸暂停低通气指数[AHI]≥10次/小时)且适合APAP治疗的患者。
APAP组:使用APAP设备进行治疗;CPAP组:PSG PAP滴定,随后进行CPAP治疗。
平均PAP依从性、爱泼沃斯嗜睡量表(ESS)、睡眠问卷功能结果(FOSQ)。
研究组之间的平均(±标准差)年龄、体重指数和诊断AHI(APAP组:28.6±18.5,CPAP组:28.3±16.0次/小时,p =无显著性差异)无差异。治疗6周后,开始使用APAP的78例患者中有84.6%以及开始使用CPAP的70例患者中有84.3%(8例在滴定后拒绝治疗)正在使用PAP,p =无显著性差异。APAP的90%水平和CPAP水平相似(10.8±3.1,11.7±2.5 cmH₂O,p = 0.07)。每晚平均PAP使用时间无差异(APAP组:4.45±2.3,CPAP组:4.0±2.3小时,p =无显著性差异)。ESS(APAP组:-4.2±4.7,CPAP组:-3.7±4.8,p =无显著性差异)和FOSQ(APAP组:2.6±3.5,CPAP组:2.2±3.7,p =无显著性差异)的改善情况无差异。
经HSAT诊断为OSA后,与PSG滴定和CPAP治疗相比,APAP治疗在PAP依从性和嗜睡改善方面效果相当。
关于本文的一篇评论发表在本期第1277页。